Zestoretic (lisinopril dihydrate-hydrochlorothiazide) - combination treatment for hypertension

Zestoretic (lisinopril dihydrate - hydrochlorothiazide)


Zestoretic (lisinopril dihydrate - hydrochlorothiazide) is a fixed-dose combination of the ACE inhibitor, lisinopril dihydrate, and the diuretic, hydrochlorothiazide, for hypertension. Zestoretic is in-licensed from Merck & Co., Inc.

Did you know?

AstraZeneca has a range of product specific and disease area websites for international healthcare professionals and patients. Links to this information can be found below.

Healthcare professionals

Patients and families opens in a new window

Links to country-specific websites can be found using the AstraZeneca websites list.

If you still have a question regarding our drug portfolio you can Contact us.